LLY — Eli Lilly and Co Balance Sheet
0.000.00%
Last trade - 00:00
- $690.55bn
- $712.94bn
- $34.12bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 2,439 | 3,681 | 3,909 | 2,212 | 2,928 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 5,542 | 6,929 | 8,127 | 8,559 | 11,336 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 13,710 | 17,462 | 18,452 | 18,035 | 25,727 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 8,405 | 8,682 | 8,985 | 10,144 | 12,914 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 39,286 | 46,633 | 48,806 | 49,490 | 64,006 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 11,775 | 12,482 | 15,053 | 17,138 | 27,293 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 36,679 | 40,992 | 39,827 | 38,840 | 53,234 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 2,607 | 5,642 | 8,979 | 10,650 | 10,772 |
Total Liabilities & Shareholders' Equity | 39,286 | 46,633 | 48,806 | 49,490 | 64,006 |
Total Common Shares Outstanding |